Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.79 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.76 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.76 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5066716 | 1.00 | DPP4 (0.79) | DPP4DPP8DPP9DPP7 | |
| SCHEMBL5066712 | 0.87 | DPP4 (0.75) | DPP4DPP8DPP9 | |
| SCHEMBL5066742 | 0.87 | DPP4 (0.75) | DPP4DPP8DPP9DPP7 | |
| SCHEMBL5070890 | 0.87 | DPP4 (0.75) | DPP4DPP8DPP9 | |
| SCHEMBL17460442 | 0.87 | DPP4 (0.79) | DPP4DPP8DPP9DPP7 | |
| Hydrochloric Acid SCHEMBL6595556 | 0.87 | DPP4 (0.79) | DPP4DPP8DPP9 | |
| SCHEMBL8274117 | 0.87 | DPP4 (0.79) | DPP4DPP8DPP9DPP7 | |
| SCHEMBL6255154 | 0.86 | DPP4 (1.00) | DPP4DPP8DPP9 | |
| SCHEMBL7337712 | 0.86 | DPP4 (0.73) | DPP4DPP8DPP9 | |
| Hydrochloric Acid SCHEMBL17460444 | 0.86 | DPP4 (0.73) | DPP4DPP8DPP9DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1595866-B1 | Cyanopyrrolidines useful for the treatment of inter alia metabolic syndrome | SANWA KAGAKU KENKYUSHO CO (JP) | 2016-06-08 | — | — | EP | disclosed |
| US-7345180-B2 | Compound inhibiting dipeptidyl peptidase IV | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 2008-03-18 | — | — | US | disclosed |
| US-20060229286-A1 | Compound inhibiting dipeptidyl peptidase IV | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 2006-10-12 | — | — | US | disclosed |
| EP-1595866-A1 | COMPOUND INHIBITING DIPEPTIDYL PEPTIDASE IV | Sanwa Kagaku Kenkyusho Co., Ltd. (JP) | 2005-11-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060229286-A1 | Compound inhibiting dipeptidyl peptidase IV | DPP4, DPP3, DPP7 | DPP4 1/4885DPP8 4/4885DPP9 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.